CAS: 1587-20-8; Trimethyl 2-Hydroxypropane-1,2,3-Tricarboxylate

相似化合物

53798-97-3 77-93-0 114340-52-2

上下游产品

CAS号67-56-1 甲醇 | CAS号77-92-9 柠檬酸 | CAS号186581-53-3 重氮甲烷 | CAS号26163-65-5 3-hydroxy-3-met... | CAS号77-89-4 乙酰柠檬酸三乙酯 | CAS号75-64-9 叔丁胺 | CAS号53798-96-2 1,5-Dimethyl Citrate | CAS号77-76-9 2,2-二甲氧基丙烷 | CAS号540-88-5 醋酸叔丁酯 | CAS号77-93-0 柠檬酸三乙酯(TEC) | CAS号4271-99-2 反-乌头酸三甲酯 | CAS号18960-42-4 2-hydroxypropan... | CAS号26163-65-5 3-hydroxy-3-met... | CAS号99-11-6 2,6-二羟基异烟酸 | CAS号53798-97-3 Dimethyl Citric acid | CAS号597-59-1 檸檬醯胺

柠檬酸置于高氯酸,硫酸体系中,化学反应 73.0H,反应生成柠檬酸三甲酯
参考文献:Synthesis And Characterisation Of Tin(II) And Tin(Iv) Citrates
标题:Synthesis And Characterisation Of Tin(II) And Tin(Iv) Citrates
摘要:一系列柠檬酸亚锡(snm(C6H4O7))(m = Sn或zn)和snmm'(C6H4O7)(m = M' = Na,K或nh4;M = Nme4,M' = H)以及相关的1,5-二甲基和1,5-二正丁基柠檬酸单亚锡(II)盐已经合成,并通过光谱方法(ir,1H,13C,119Sn NMR,119Sn Mössbauer)进行了表征.二聚柠檬酸亚锡(II)1,5-二甲基柠檬酸盐和氧化产物sn(Nme4)2(C6H5O7)2.3.5H2O的晶体结构也已确定.
Doi:10.1039/a704511E

专利信息

专利号:US-11717498-B2
优先权日:2013-12-31
标题 :Methods of treatment using amphetamine controlled release, prodrug, and abuse deterrent dosage forms
发明人：POPP KARL; MECKLER HAROLD
权利人:Chemapotheca LLC; PHARMAPOTHECA A INC
摘要:The invention also relates to pharmaceutical compositions comprising highly pure amphetamine and amphetamine-class compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds, and to methods of manufacturing, delivering, and using the amphetamine compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds.

专利号:US-4249018-A
优先权日:1979-08-27
标 题 :Synthesis of citric acid or citrates
发明人：GINSBURG DAVID; MAYER WILFRIED J W; WEXLER ALLAN
权利人:MILES LAB
摘要:Citric acid or a citrate ester can be prepared by the process comprising the steps of oxidizing isotetralin to form cyclodeca-1,6-diene-4,9-dione, converting the dione into the bis-cyanohydrin derivative, ozonating the bis-cyanohydrin and recovering citric acid or a citrate ester. It is preferred that the isotetralin be prepared by reduction of naphthalene.

专利号:US-5739395-A
优先权日:1997-01-10
标题 :Method for synthesis of rhizoferrin
发明人：BERGERON JR RAYMOND J
权利人:UNIV FLORIDA
摘要:A method of synthesizing rhizoferrin and analogues thereof comprising acylating a protected polyamine with a citric acid diester; hydrolyzing the resulting amide to produce an N-protected rhizoferrin or analog thereof; and de-protecting the intermediate to produce rhizoferrin or the analog thereof.

专利号:US-7825268-B2
优先权日:2003-12-23
标 题:Alkoxylactones, alkoxylactams and alkoxythiolactams for controlling processes based on microbial interaction
发明人：STUMPE STEFAN; BREVES ROLAND; HUCHEL URSULA; JANSSEN FRANK; HAETZELT ANDRE
权利人:HENKEL AG & CO KGAA
摘要:Compounds of the Formula I, n nwherein A 1 is O or NH; A 2 is O or S; each of R 1 and R 2 is independently hydrogen, a methyl or C 2 -C 8 -saturated or mono- or doubly unsaturated, branched or linear hydrocarbon group; and R 3 is a C 1 -C 18 -saturated or mono- or doubly unsaturated, branched or linear hydrocarbon group wherein, each of R 1 , R 2 and R 3 comprises a heteroatom selected from the group consisting of O and S in the chain and/or is mono- or multiply-substituted by a substituent selected from the group consisting of halogen, hydroxy, C 1 -C 6 -alkyl, trifluoromethyl, C 1 -C 6 -alkoxy, C 6 -C 10 -aryl, and C 1 -C 6 -alkyl-C 6 -C 10 -aryl are useful for controlling the interaction process between microorganisms such as in the development and/or maturation of biofilms; multicellular swarm behavior; the concerted development of antibiotic resistances; the concerted synthesis of antibiotics; the concerted synthesis of pigments; the concerted production of extracellular enzymes; or the concerted production of virulence factors.

专利号:US-12208068-B2
优先权日:2013-12-31
标题:Amphetamine controlled release, prodrug, and abuse-deterrent dosage forms
发明人：POPP KARL; MECKLER HAROLD
权利人:PHARMAPOTHECA A INC
摘要:The invention also relates to processes for producing abuse deterrent pharmaceutical compositions comprising highly pure amphetamine and amphetamine-class compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds, and to methods of manufacturing, delivering, and using the amphetamine compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds.

专利号:US-2025213502-A1
优先权日:2016-02-24
标 题 :Amphetamine Controlled Release, Prodrug, and Abuse-deterrent Dosage Forms
发明人：POPP KARL; MECKLER HAROLD
权利人:PHARMAPOTHECA A INC
摘要:The invention also relates to pharmaceutical compositions comprising highly pure amphetamine and amphetamine-class compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds, and to methods of manufacturing, delivering, and using the amphetamine compounds resulting from the synthesis of chiral and racemic amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds.